CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Dallas, Texas, United States and 44 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Dallas, Texas, United States and 17 other locations
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Irving, Texas, United States and 26 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Dallas, Texas, United States of America and 24 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Dallas, Texas, United States of America and 89 other locations
The main purpose of this study is to evaluate the safety, tolerability of LY4086940 and how it is processed in the body.Participation in Part A of th...
Phase 1
Dallas, Texas, United States and 3 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Mesquite, Texas, United States and 40 other locations
oral capsule of ORMD-0801 at several doses in patients with Type 2 Diabetes Mellitus (T2DM) who have not responded well to other glucose-low...
Phase 3
Dallas, Texas, United States and 1 other location
A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinic...
Dallas, Texas, United States
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
Phase 3
Dallas, Texas, United States and 42 other locations
Clinical trials
Research sites
Resources
Legal